Pharmacological and biochemical studies on 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004): a new sulphonamide with anticonvulsant and carbonic anhydrase inhibitory properties.
D000818:Animals; D000927:Anticonvulsants; D002257:Carbonic Anhydrase Inhibitors; D004231:Diuresis / Q000187:drug effects; D004597:Electroshock; D004789:Enzyme Activation; D007928:Lethal Dose 50; D051379:Mice; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy; D013331:Strychnine / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000097:blood / Q000494:pharmacology*
D000927:Anticonvulsants; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D010672:Phenytoin; D013331:Strychnine; D010433:Pentylenetetrazole; D010634:Phenobarbital